Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol

NCT02848612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 459

Last updated 2018-10-12

No results posted yet for this study

Summary

To prevent thromboembolic complications, the embolization procedure is performed under prophylactic unfractionated heparin, the efficacy of which is monitored by point-of- care testing according to international guidelines. However, these guidelines are based on limited scientific evidence and the ideal level of anticoagulation required has not been precisely defined. Furthermore, the correlation between the point-of- care tests used at Amiens University Hospital and the reference methods used in the laboratory varies considerably according to the available literature.

Conditions

  • Aneurysm

Interventions

DRUG

anticoagulation by unfractionated heparin

anticoagulation by unfractionated heparin

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Emmanuel LORNE, MD, PhD · CHU Amiens

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-20
Primary Completion
2016-07-15
Completion
2016-07-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02848612 on ClinicalTrials.gov